Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。
該当コードがありません。
から:
次の項目別のソート:
日付受信時刻ニュースソース見出しコード企業名
2024/07/0815 : 30GlobeNewswire Inc.VIRBAC: exceptional first-half growth and guidance raised for 2024EU:VIRPVirbac SA
2024/07/0815 : 30GlobeNewswire Inc.VIRBAC announces executive management changesEU:VIRPVirbac SA
2024/07/0815 : 30GlobeNewswire Inc.Virbac annonce des changements au sein de sa direction généraleEU:VIRPVirbac SA
2024/07/0815 : 30GlobeNewswire Inc.VIRBAC: croissance exceptionnelle sur le premier semestre et relèvement de la guidance pour l’année 2024EU:VIRPVirbac SA
2024/07/0815 : 22Business WireInstitut für Pathologie der Technischen Universität München erzielt hervorragende Ergebnisse beim QuIP Proficiency-Test zur Erkennung von ESR1-Mutationen mit einem Hedera Dx Liquid Biopsy Testpanel
2024/07/0815 : 19PR Newswire (US)Sirnaomics Announces Interim Results for Successful Completion of the Second Cohort of Phase I Clinical Study of GalNAc-Based RNAi Therapeutic STP122G for Anticoagulant Therapeutics
2024/07/0815 : 16Alliance NewsAlliance NewsIrish construction activity decline accelerates in June - PMI
2024/07/0815 : 14GlobeNewswire Inc.Preliminary data on early redemptions (prepayments)
2024/07/0815 : 12Alliance NewsAlliance NewsTOP NEWS: German trade surplus grows as exports and imports both slip
2024/07/0815 : 10GlobeNewswire Inc.Mujtaba Khalid, Islamic finance thought leader, joins XTCC Advisory Team
2024/07/0815 : 07GlobeNewswire Inc.OKX Wallet Now Integrated with The Beacon, an Action RPG
2024/07/0815 : 00GlobeNewswire Inc.LEXIBOOK : RÉSULTATS ANNUELS 2023-24 CONFORMES AUX ATTENTES : CHIFFRE D’AFFAIRES ANNUEL À 58,6M€ (+14,4%). REX ET RN EN CROISSANCE RESPECTIVEMENT À +6,0M€ ET À +5,0M€ GRACE A UNE CONJONCTION EXCEPTIONNELLE DE FACTEURS POSITIFS.EU:ALLEXLexibook Linguistic Electronic System SA
2024/07/0815 : 00GlobeNewswire Inc.Memo Therapeutics AG appoints Paul Carter as Chairperson
2024/07/0815 : 00GlobeNewswire Inc.Myricx Bio Announces £90m ($114m) Series A Financing to Advance its Novel NMTi-ADC Therapeutics into Clinical DevelopmentNYSE:ADCTADC Therapeutics SA
2024/07/0815 : 00Business WireSignum Surgical Granted FDA De Novo Clearance for BioHealx™
2024/07/0815 : 00Business WireEpsilogen announces CTA approval for Phase Ib trial of MOv18 IgE in platinum-resistant ovarian cancer
2024/07/0815 : 00GlobeNewswire Inc.Renforcement en Europe
2024/07/0815 : 00GlobeNewswire Inc.Myricx Bio Announces £90m ($114m) Series A Financing to Advance its Novel NMTi-ADC Therapeutics into Clinical DevelopmentNASDAQ:CGCarlyle Group Inc
2024/07/0815 : 00GlobeNewswire Inc.Volta Finance Limited - Dividend DeclarationLSE:VTAVolta Finance Limited
2024/07/0815 : 00GlobeNewswire Inc.EUR 200 million share buyback program beginsLSE:31QWAegon Nv
2024/07/0815 : 00GlobeNewswire Inc.EUR 200 million share buyback program beginsLSE:AGNAegon Nv
2024/07/0815 : 00GlobeNewswire Inc.EUR 200 million share buyback program beginsTG:AENDRegistered Shares
2024/07/0815 : 00GlobeNewswire Inc.Evolution de la Gouvernance de la sociétéEU:OREGEOrege
2024/07/0815 : 00GlobeNewswire Inc.EUR 200 million share buyback program beginsBIT:AGNAegon N V
2024/07/0815 : 00GlobeNewswire Inc.EUR 200 million share buyback program beginsXE:AENDAegon N V
2024/07/0815 : 00GlobeNewswire Inc.LEXIBOOK: 2023-24 ANNUAL RESULTS IN LINE WITH EXPECTATIONS: ANNUAL SALES AT €58.6M (+14.4%). EBIT AND NET RESULT UP RESPECTIVELY TO +6.0M€ AND +5.0M€ THANKS TO AN EXCEPTIONAL CONJUNCTION OF POSITIVE FACTORS.EU:ALLEXLexibook Linguistic Electronic System SA
2024/07/0815 : 00Business WireSpineGuard : Réalisation de l’augmentation de capital avec maintien du droit préférentiel de souscription pour un montant brut de 1,13 M€EU:ALSGDSpineguard
2024/07/0815 : 00GlobeNewswire Inc.Strengthened presence in Europe
2024/07/0815 : 00GlobeNewswire Inc.OKX to List XRADERS' XR Token on its Spot Market, Expanding Trading Options
2024/07/0815 : 00GlobeNewswire Inc.Transaction in Own SharesTG:PANPaypoint PLC

最近閲覧した銘柄

Delayed Upgrade Clock